In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae:: Application to breakpoint determinations

被引:207
作者
Andes, D [1 ]
Craig, WA [1 ]
机构
[1] Univ Wisconsin, Madison, WI USA
关键词
D O I
10.1128/AAC.42.9.2375
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vivo activities of amoxicillin and amoxicillin-clavulanate against 17 strains of Streptococcus pneumoniae with penicillin MICs of 0,12-8.0 mg/liter were assessed in a cyclophosphamide-induced neutropenic murine thigh infection model. Renal impairment was produced by administration of uranyl nitrate to prolong the amoxicillin half-life in the mice from 21 to 65 min, simulating human pharmacokinetics. Two hours after thigh infection with 10(5) to 10(6) CFU, groups of mice were treated with 7 mg of amoxicillin per kg of body weight alone or combined with clavulanate (ratio, 4:1) every 8 h for 1 and 4 days, There was an excellent correlation between the MIC of amoxicillin (0.03 to 5.6 mg/liter) and (i) the change in log(10) CFU/thigh at 24 h and (ii) survival after 4 days of therapy. Organisms for which MICs were 2 mg/liter or less were killed at 1.4 to 4.2 and 1.6 to 4.1 log(10) CFU/thigh at 24 h by amoxicillin and amoxicillin-clavulanate, respectively. The four strains for which MICs were >4 mg/liter grew 0.2 to 2.6 and 0.6 to 2.3 logs at 24 h despite therapy with amoxicillin and amoxicillin-clavulanate, respectively. Infection was uniformly fatal by 72 h in untreated mice. Amoxicillin therapy resulted in no mortality with organisms for which MICs were 1 mg/liter or less, 20 to 40% mortality with organisms for which MICs were 2 mg/liter, and 80 to 100% mortality with organisms for which MICs were 4.0-5.6 mg/liter, Lower and higher doses (0.5, 2, and 20 mg/kg) of amoxicillin were studied against organisms for which MICs were near the breakpoint, These studies demonstrate that a reduction of 1 log,, or greater in CFU/thigh at 24 h is consistently observed when amoxicillin levels exceed the MIC for 25 to 30% of the dosing interval, These studies would support amoxicillin (and amoxicillin-clavulanate) MIC breakpoints of I mg/liter for susceptible, 2 mg/liter for intermediate, and 4 mg/liter for resistant strains of S. pneumoniae.
引用
收藏
页码:2375 / 2379
页数:5
相关论文
共 24 条
[1]  
ABBOUD MF, 1959, AM J MED, V104, P226
[2]  
[Anonymous], ANTIBIOTICS LAB MED
[3]   IMIPENEM-CILASTATIN THERAPY IN A CHILD WITH MENINGITIS CAUSED BY A MULTIPLY RESISTANT PNEUMOCOCCUS [J].
ASENSI, F ;
PEREZTAMARIT, D ;
OTERO, MC ;
GALLEGO, M ;
LLANES, S ;
ABADIA, C ;
CANTO, E .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (12) :895-895
[4]  
BARRY B, 1993, 33RD INT C ANT AG CH, P370
[5]  
BLOCK S, 1993, 33RD INT C ANT AG CH, P311
[6]  
CRAIG W, 1993, EUR J CLIN MICROBIOL, V12, P55
[7]  
CRAIG W, 1993, 33 INT C ANT AG CHEM, P135
[8]   Pharmacokinetics and pharmacodynamics of antibiotics in otitis media [J].
Craig, WA ;
Andes, D .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) :255-259
[9]   INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J].
CRAIG, WA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) :89-96
[10]   PHARMACODYNAMICS OF AMIKACIN INVITRO AND IN MOUSE THIGH AND LUNG INFECTIONS [J].
CRAIG, WA ;
REDINGTON, J ;
EBERT, SC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :29-40